Anti-CD30 immunotoxins with native and recombinant dianthin 30
- PMID: 7882380
- PMCID: PMC11037669
- DOI: 10.1007/BF01520292
Anti-CD30 immunotoxins with native and recombinant dianthin 30
Abstract
Immunotoxins were prepared with a Ber-H2 (anti-CD30) monoclonal antibody and native or recombinant dianthin 30, a ribosome-inactivating protein from Dianthus caryophyllus (carnation). Both immunotoxins selectively inhibited protein synthesis by CD30+ cell lines D430B (lymphoblastoid, infected with Epstein-Barr virus), L428 and L540 (both from Hodgkin's lymphoma). IC50 values (concentrations, as dianthin, causing 50% inhibition) ranged from 324 pM to 479 pM (immunotoxin with native dianthin 30) or from 45 pM to 182 pM (immunotoxin with recombinant dianthin 30). The effect of either immunotoxin on protein synthesis by the CD30+ cell line K562 (from a chronic myeloid leukaemia) was not different from that of free dianthin (IC50 higher than nM).
Similar articles
-
Dianthin and Its Potential in Targeted Tumor Therapies.Toxins (Basel). 2019 Oct 11;11(10):592. doi: 10.3390/toxins11100592. Toxins (Basel). 2019. PMID: 31614697 Free PMC article. Review.
-
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice.Br J Haematol. 1996 Mar;92(4):872-9. doi: 10.1046/j.1365-2141.1995.404942.x. Br J Haematol. 1996. PMID: 8616080
-
Targeting of type 1 ribosome-inactivating proteins to CD30+ or CD25+ hematologic neoplasias by bispecific antibodies.J Hematother. 1995 Oct;4(5):429-32. doi: 10.1089/scd.1.1995.4.429. J Hematother. 1995. PMID: 8581380
-
An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins.Haematologica. 1999 Nov;84(11):988-95. Haematologica. 1999. PMID: 10553158
-
Bispecific monoclonal antibodies for the targeting of type I ribosome-inactivating proteins against hematological malignancies.Methods Mol Biol. 2001;166:177-92. doi: 10.1385/1-59259-114-0:177. Methods Mol Biol. 2001. PMID: 11217367 Review. No abstract available.
Cited by
-
Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.Curr Pharm Des. 2014;20(42):6584-643. doi: 10.2174/1381612820666140826153913. Curr Pharm Des. 2014. PMID: 25341935 Free PMC article. Review.
-
Targeting CD30 in anaplastic large cell lymphoma.Curr Hematol Malig Rep. 2012 Dec;7(4):285-91. doi: 10.1007/s11899-012-0137-y. Curr Hematol Malig Rep. 2012. PMID: 23065407 Review.
-
Hyperuricaemia, Xanthine Oxidoreductase and Ribosome-Inactivating Proteins from Plants: The Contributions of Fiorenzo Stirpe to Frontline Research.Molecules. 2017 Jan 27;22(2):206. doi: 10.3390/molecules22020206. Molecules. 2017. PMID: 28134797 Free PMC article. Review.
-
Dianthin and Its Potential in Targeted Tumor Therapies.Toxins (Basel). 2019 Oct 11;11(10):592. doi: 10.3390/toxins11100592. Toxins (Basel). 2019. PMID: 31614697 Free PMC article. Review.
-
Constitutive overexpression of a novel 21 kDa protein by Hodgkin lymphoma and aggressive non-Hodgkin lymphomas.Mol Cancer. 2008 Jan 24;7:12. doi: 10.1186/1476-4598-7-12. Mol Cancer. 2008. PMID: 18218123 Free PMC article.
References
-
- Barbieri L, Battelli MG, Stirpe F. Ribosome-inactivating proteins from plants. Biochim Biophys Acta. 1993;1154:327. - PubMed
-
- Endo Y. Mechanism of action of ricin and related toxins on the inactivation of ribosomes. In: Frankel AE, editor. Immunotoxins. Boston: Kluwer; 1988. p. 75. - PubMed
-
- Ramakrishnan S, Fryxell D, Mohanraj D, Olson M, Li BY. Cytotoxic conjugates containing translational inhibitory proteins. Annu Rev Pharmacol Toxicol. 1992;32:579. - PubMed
-
- Vitetta ES, Thorpe PE, Uhr JW. Immunotoxins: magic bullets or misguided missiles? Immunol Today. 1993;14:252. - PubMed
-
- Pastan I, Chaudhary V, FitzGerald D. Recombinant toxins as novel therapeutic agents. Annu Rev Biochem. 1992;61:331. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources